Construction of aminoglycoside-sensitive burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamicin protection assay

Applied and Environmental Microbiology

Volumn 76, Issue 10, 2010, Pages 3170-3176

  Hamad, Mohamad A ^a   Skeldon, Alexander M ^a   Valvano, Miguel A ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDES; BURKHOLDERIA; CYSTIC FIBROSIS; EFFLUX PUMPS; EPITHELIAL CELLS; EUKARYOTIC CELLS; EXTRACELLULAR; HIGH RESISTANCE; INTRACELLULAR BACTERIA; LOW CONCENTRATIONS; MURINE MACROPHAGES; PARENTAL STRAINS; PROTECTION ASSAY;

CELL MEMBRANES; CYTOLOGY; ENZYME ACTIVITY; MACROPHAGES;

BACTERIOLOGY;

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; GENTAMICIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL DISEASE; BACTERIOPHAGE; BACTERIUM; BIOASSAY; CONCENTRATION (COMPOSITION); PATHOGEN;

ANIMAL; ARTICLE; BURKHOLDERIA CEPACIA COMPLEX; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MACROPHAGE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOUSE; PHAGOSOME;

AMINOGLYCOSIDES; ANIMALS; ANTI-BACTERIAL AGENTS; BURKHOLDERIA CEPACIA COMPLEX; GENTAMICINS; HUMANS; MACROPHAGES; MICE; MICROBIAL SENSITIVITY TESTS; PHAGOSOMES;

BACTERIA (MICROORGANISMS); BURKHOLDERIA CENOCEPACIA; EUKARYOTA; MURINAE;

EID: 77952281516     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.03024-09     Document Type: Article

References (59)

1. Aaron, S. D., W. Ferris, D. A. Henry, D. P. Speert, and N. E. Macdonald. 2000. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am. J. Respir. Crit. Care Med. 161:1206-1212.
2. Altschul, S. F., and D. J. Lipman. 1990. Protein database searches for multiple alignments. Proc. Natl. Acad. Sci. U. S. A. 87:5509-5513.
3. Al-Younes, H. M., T. Rudel, and T. F. Meyer. 1999. Characterization and intracellular trafficking pattern of vacuoles containing Chlamydia pneumoniae in human epithelial cells. Cell. Microbiol. 1:237-247.
4. Böttger, E. C., B. Springer, T. Prammananan, Y. Kidan, and P. Sander. 2001. Structural basis for selectivity and toxicity of ribosomal antibiotics. EMBO Rep. 2:318-323.
5. Breitbach, K., G. W. Sun, J. Köhler, K. Eske, P. Wongprompitak, G. Tan, Y. Liu, Y.-H. Gan, and I. Steinmetz. 2009. Caspase-1 mediates resistance in murine melioidosis. Infect. Immun. 77:1589-1595.
6. Burns, J. L., M. Jonas, E. Y. Chi, D. K. Clark, A. Berger, and A. Griffith. 1996. Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect. Immun. 64:4054-4059.
7. Buroni, S., M. R. Pasca, R. S. Flannagan, S. Bazzini, A. Milano, I. Bertani, V. Venturi, M. A. Valvano, and G. Riccardi. 2009. Assessment of three resistance-nodulation-cell division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance. BMC Microbiol. 9:200.
8. Burtnick, M. N., P. J. Brett, V. Nair, J. M. Warawa, D. E. Woods, and F. C. Gherardini. 2008. Burkholderia pseudomallei type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages. Infect. Immun. 76:2991-3000.
9. Burtnick, M. N., D. Deshazer, V. Nair, F. C. Gherardini, and P. J. Brett. 2010. Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages. Infect. Immun. 78:88-99.
10. Caraher, E., C. Duff, T. Mullen, S. Mc Keon, P. Murphy, M. Callaghan, and S. McClean. 2007. Invasion and biofilm formation of Burkholderia dolosa is comparable with Burkholderia cenocepacia and Burkholderia multivorans. J. Cyst. Fibros. 6:49-56. (Pubitemid 46029889)
11. Chantratita, N., V. Wuthiekanun, K. Boonbumrung, R. Tiyawisutsri, M. Vesaratchavest, D. Limmathurotsakul, W. Chierakul, S. Wongratanacheewin, S. Pukritiyakamee, N. J. White, N. P. J. Day, and S. J. Peacock. 2007. Biological relevance of colony morphology and phenotypic switching by Burkholderia pseudomallei. J. Bacteriol. 189:807-817.
12. Choi, K. H., T. Mima, Y. Casart, D. Rholl, A. Kumar, I. R. Beacham, and H. P. Schweizer. 2008. Genetic tools for select-agent-compliant manipulation of Burkholderia pseudomallei. Appl. Environ. Microbiol. 74:1064-1075.
13. Chuaygud, T., S. Tungpradabkul, S. Sirisinha, K. L. Chua, and P. Utaisincharoen. 2008. A role of Burkholderia pseudomallei flagella as a virulent factor. Trans. R. Soc. Trop. Med. Hyg. 102(Suppl. 1):S140-S144.
14. Coenye, T., and P. Vandamme. 2003. Diversity and significance of Burkholderia species occupying diverse ecological niches. Environ. Microbiol. 5:719-729.
15. Cohen, S. N., A. C. Chang, and L. Hsu. 1972. Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA. Proc. Natl. Acad. Sci. U. S. A. 69:2110-2114.
16. Conway, S. P., K. G. Brownlee, M. Denton, and D. G. Peckham. 2003. Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis. Am. J. Respir. Med. 2:321-332.
17. Craig, F. F., J. G. Coote, R. Partem, J. H. Freer, and N. J. Gilmour. 1989. A plasmid which can be transferred between Escherichia coli and Pasteurella haemolytica by electroporation and conjugation. J. Gen. Microbiol. 135: 2885-2890.
18. Diop, D., C. Chauvin, and O. Jean-Jean. 2007. Aminoglycosides and other factors promoting stop codon readthrough in human cells. C. R. Biol. 330: 71-79.
19. Drevets, D. A., B. P. Canono, P. J. Leenen, and P. A. Campbell. 1994. Gentamicin kills intracellular Listeria monocytogenes. Infect. Immun. 62: 2222-2228.
20. Elsinghorst, E. A. 1994. Measurement of invasion by gentamicin resistance. Methods Enzymol. 236:405-420.
21. Figurski, D. H., and D. R. Helinski. 1979. Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc. Natl. Acad. Sci. U. S. A. 76:1648-1652.
22. Flannagan, R. S., T. Linn, and M. A. Valvano. 2008. A system for the construction of targeted unmarked gene deletions in the genus Burkholderia. Environ. Microbiol. 10:1652-1660.
23. Govan, J. R., P. H. Brown, J. Maddison, C. J. Doherty, J. W. Nelson, M. Dodd, A. P. Greening, and A. K. Webb. 1993. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342:15-19.
24. Hamad, M. A., S. L. Zajdowicz, R. K. Holmes, and M. I. Voskuil. 2009. An allelic exchange system for compliant genetic manipulation of the select agents Burkholderia pseudomallei and Burkholderia mallei. Gene 430:123-131.
25. Isles, A., I. Maclusky, M. Corey, R. Gold, C. Prober, P. Fleming, and H. Levison. 1984. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104:206-210.
26. Jones, A. L., T. J. Beveridge, and D. E. Woods. 1996. Intracellular survival of Burkholderia pseudomallei. Infect. Immun. 64:782-790.
27. Jones, A. M., M. E. Dodd, and A. K. Webb. 2001. Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas. Eur. Respir. J. 17:295-301.
28. Judy, B. M., G. C. Whitlock, A. G. Torres, and D. M. Estes. 2009. Comparison of the in vitro and in vivo susceptibilities of Burkholderia mallei to ceftazidime and levofloxacin. BMC Microbiol. 9:88.
29. Lamothe, J., K. K. Huynh, S. Grinstein, and M. A. Valvano. 2007. Intracellular survival of Burkholderia cenocepacia in macrophages is associated with a delay in the maturation of bacteria-containing vacuoles. Cell. Microbiol. 9:40-53.
30. Lamothe, J., S. Thyssen, and M. A. Valvano. 2004. Burkholderia cepacia complex isolates survive intracellulary without replication within acidic vacuoles of Acanthamoeba pdiyphaga. Cell. Microbiol. 6:1127-1138. (Pubitemid 39517483)
31. Landers, P., K. G. Kerr, T. J. Rowbotham, J. L. Tipper, P. M. Keig, E. Ingham, and M. Denton. 2000. Survival and growth of Burkholderia cepacia within the free-living amoeba Acanthamoeba polyphaga. Eur. J. Clin. Microbiol. Infect. Dis. 19:121-123.
32. Law, R. J., J. N. Hamlin, A. Sivro, S. J. McCorrister, G. A. Cardama, and S. T. Cardona. 2008. A functional phenylacetic acid catabolic pathway is required for full pathogenicity of Burkholderia cenocepacia in the Caenorhabditis elegans host model. J. Bacteriol. 190:7209-7218.
33. Lipuma, J. J. 2003. Burkholderia cepacia complex as human pathogens. J. Nematol. 35:212-217.
34. LiPuma, J. J., S. E. Dasen, D. W. Nielson, R. C. Stern, and T. L. Stull. 1990. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 336:1094-1096.
35. Loutet, S. A., S. J. Bartholdson, J. R. Govan, D. J. Campopiano, and M. A. Valvano. 2009. Contributions of two UDP-glucose dehydrogenases to viability and polymyxin B resistance of Burkholderia cenocepacia. Microbiology 155:2029-2039.
36. MacDonald, K. L., and D. P. Speert. 2008. Differential modulation of innate immune cell functions by the Burkholderia cepacia complex: Burkholderia cenocepacia but not Burkholderia multivorans disrupts maturation and induces necrosis in human dendritic cells. Cell. Microbiol. 10:2138-2149.
37. Mahenthiralingam, E., T. Coenye, J. W. Chung, D. P. Speert, J. R. Govan, P. Taylor, and P. Vandamme. 2000. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J. Clin. Microbiol. 38:910-913.
38. Maloney, K. E., and M. A. Valvano. 2006. The mgtC gene of Burkholderia cenocepacia is required for growth under magnesium limitation conditions and intracellular survival in macrophages. Infect. Immun. 74:5477-5486.
39. Marolda, C. L., B. Hauröder, M. A. John, R. Michel, and M. A. Valvano. 1999. Intracellular survival and saprophytic growth of isolates from the Burkholderia cepacia complex in free-living amoebae. Microbiology 145:1509-1517.
40. Martin, D. W., and C. D. Mohr. 2000. Invasion and intracellular survival of Burkholderia cepacia. Infect. Immun. 68:24-29.
41. Menashe, O., E. Kaganskaya, T. Baasov, and S. Yaron. 2008. Aminoglycosides affect intracellular Salmonella enterica serovars Typhimurium and Virchow. Antimicrob. Agents Chemother. 52:920-926.
42. Moore, R. A., D. DeShazer, S. Reckseidler, A. Weissman, and D. E. Woods. 1999. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob. Agents Chemother. 43:465-470.
43. Pruksachartvuthi, S., N. Aswapokee, and K. Thankerngpol. 1990. Survival of Pseudomonas pseudomallei in human phagocytes. J. Med. Microbiol. 31:109-114.
44. Ribot, W. J., and R. L. Ulrich. 2006. The animal pathogen-like type III secretion system is required for the intracellular survival of Burkholderia mallei within J774.2 macrophages. Infect. Immun. 74:4349-4353.
45. Saini, L. S., S. B. Galsworthy, M. A. John, and M. A. Valvano. 1999. Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation. Microbiology 145:3465-3475.
46. Sajjan, S. U., L. A. Carmody, C. F. Gonzalez, and J. J. LiPuma. 2008. A type IV secretion system contributes to intracellular survival and replication of Burkholderia cenocepacia. Infect. Immun. 76:5447-5455.
47. Sajjan, U. S., J. H. Yang, M. B. Hershenson, and J. J. LiPuma. 2006. Intracellular trafficking and replication of Burkholderia cenocepacia in human cystic fibrosis airway epithelial cells. Cell. Microbiol. 8:1456-1466.
48. Saldfas, M. S., J. Lamothe, R. Wu, and M. A. Valvano. 2008. Burkholderia cenocepacia requires the RpoN sigma factor for biofilm formation and intracellular trafficking within macrophages. Infect. Immun. 76:1059-1067.
49. Saldías, M. S., X. Ortega, and M. A. Valvano. 2009. Burkholderia cenocepacia O antigen lipopolysaccharide prevents phagocytosis by macrophages and adhesion to epithelial cells. J. Med. Microbiol. 58:1542-1548.
50. Saldfas, M. S., and M. A. Valvano. 2009. Interactions of Burkholderia cenocepacia and other Burkholderia cepacia complex bacteria with epithelial and phagocytic cells. Microbiology 155:2809-2817.
51. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
52. Sandoval, R. M., and B. A. Molitoris. 2004. Gentamicin traffics retrograde through the secretory pathway and is released in the cytosol via the endoplasmic reticulum. Am. J. Physiol. Renal. Physiol. 286:F617-F624.
53. Speert, D. P. 2002. Advances in Burkholderia cepacia complex. Paediatr. Respir. Rev. 3:230-1135
54. Steele-Mortimer, O. 2008. Infection of epithelial cells with Salmonella enterica. Methods Mol. Biol. 431:201-211.
55. Stevens, M. P., M. W. Wood, L. A. Taylor, P. Monaghan, P. Hawes, P. W. Jones, T. S. Wallis, and E. E. Galyov. 2002. An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen. Mol. Microbiol. 46:649-659.
56. Taylor, J. B., L. A. Hogue, M. J. Walter, S. L. Brody, and C. L. Cannon. 2010. Entry of Burkholderia organisms into respiratory epithelium: CFTR. microfilament and microtubule dependence. J. Cyst. Fibros. 9:36-43.
57. Trunck, L. A., K. L. Propst, V. Wuthiekanun, A. Tuanyok, S. M. BeckstromSternberg, J. S. Beckstrom-Sternberg, S. J. Peacock, P. Keim, S. W. Dow, and H. P. Schweizer. 2009. Molecular basis of rare aminoglycoside susceptibility and pathogenesis of Burkholderia pseudomallei clinical Isolates from Thailand. PLoS Negl. Trop. Dis. 3:e519.
58. Via, L. E., R. A. Fratti, M. McFalone, E. Pagan-Ramos, D. Deretic, and V. Deretic. 1998. Effects of cytokines on mycobacterial phagosome maturation. J. Cell Sci. 111:897-905.
59. Vial, L., M. Groleau, M. Lamarche, G. Filion, J. Castonguay-Vanier, V. Dekimpe, F. Daigle, S. Charette, and E. Déziel. 2010. Phase variation has a role in Burkholderia ambifaria niche adaptation. ISME J. 4:49-60.